Forward Pharma A/S
FWPAYOTCHealthcare
$300.00
$-100.50(-25.09%)
Market Cap$7445700
P/E Ratio—
52W High$882.85626
52W Low$200.0
Forward Pharma A/S (FWPAY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · FWPAY · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $1.25B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.03B |
| Gross Profit | $0.00B | $0.00B | $0.00B | $0.00B | $1.23B |
| Gross Margin %(computed) | — | — | — | — | 98.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.02B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.01B | $0.02B |
| Total Operating Expenses | $0.00B | $0.00B | $0.01B | $0.01B | $0.04B |
| Operating Income | ($0.00B) | ($0.00B) | ($0.01B) | ($0.01B) | $1.19B |
| Operating Margin %(computed) | — | — | — | — | 94.99% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.00B) | ($0.01B) | ($0.00B) | ($0.01B) | $1.18B |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.00B) | $0.27B |
| Net Income | ($0.00B) | ($0.01B) | ($0.00B) | ($0.01B) | $0.92B |
| Net Margin %(computed) | — | — | — | — | 73.37% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-77.41 | $-268.72 | $-177.58 | $-368.51 | $9639.99 |
| Wtd Avg Shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.01B) | ($0.00B) | ($0.01B) | ($0.01B) | $1.19B |
| EBITDA Margin %(computed) | — | — | — | — | 95.03% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Forward Pharma A/S data
About Forward Pharma A/S (FWPAY) Income Statement
Forward Pharma A/S (FWPAY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2021, FWPAY reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of ($0.00B) — a net profit margin of —.
Frequently asked questions
FWPAY · 4 questionsForward Pharma A/S (FWPAY) reported revenue of $0.00B for 2021, down —% year-over-year.
FWPAY revenueFWPAY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09